| Followers | 201 |
| Posts | 21385 |
| Boards Moderated | 0 |
| Alias Born | 01/09/2019 |
Saturday, July 27, 2024 12:38:48 PM
Very concerning? One day creates that much consternation for you? I’m sorry to hear that. I often hear how traders/investors trade on emotions rather than due diligence. It still gets me to some degree as well although I have been trading for nearly 35 years. Therefore, I feel bad for you as I have been there before and can relate.
Just a thought, if you are so concerned, you may want to look investments that are not so risky. Any medical/bio company lives and dies by the extreme daily risk of how good, safe, effective and how long they can hold that market share and so on.
You may want to look at 1-2 month t-bills instead and they have a guaranteed yield of circa 5.25%. Not bad but will obviously drop when the fed cuts their target rate range by 25 bps. Therefore, you do incur some reinvestment risk.
Good luck bud. Been there done that. Thankfully I am not experiencing your emotions as I am 100% steadfast on my DD and know comfortably the technology I own through Vivos clearly has a future and a lot can happen over the next several days/weeks/months.
Just a thought, if you are so concerned, you may want to look investments that are not so risky. Any medical/bio company lives and dies by the extreme daily risk of how good, safe, effective and how long they can hold that market share and so on.
You may want to look at 1-2 month t-bills instead and they have a guaranteed yield of circa 5.25%. Not bad but will obviously drop when the fed cuts their target rate range by 25 bps. Therefore, you do incur some reinvestment risk.
Good luck bud. Been there done that. Thankfully I am not experiencing your emotions as I am 100% steadfast on my DD and know comfortably the technology I own through Vivos clearly has a future and a lot can happen over the next several days/weeks/months.
Everything I say is my educated opinion and is NOT investment advice
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
